Jones Day Issues & Appeals, Intellectual Property, and Product Liability practices selected by Law360 as 2019 Practice Groups of the Year
Jones Day was recognized by the legal publication Law360 for its 2019 "Practice Groups of the Year" awards in the Appellate, Intellectual Property, and Product Liability categories. Now in their tenth year, the awards "honor the law firms behind the litigation wins and major deals that resonated throughout the legal industry in the past year." Law360 editors selected 182 winners across 38 practice areas from 776 submissions.
This is the fifth time Jones Day has been named an Appellate Practice Group of the Year, having obtained significant Supreme Court victories in the past year alone for Merck, Sharpe & Dohme Corporation, CBS Corporation, and the American Legion, among others, and in federal and state appellate courts. Jones Day represented Merck, Sharp & Dohme Corp. in its unanimous win before the Supreme Court in a products liability case involving Merck's prescription medicine Fosamax®; the Court held that a judge, not a jury, should assess a pharmaceutical manufacturer's preemption defense, and should do so using ordinary legal burdens, not a heightened clear-and-convincing-evidence standard.
For CBS Corporation, Jones Day successfully challenged the Third Circuit's broad duty-to-warn standard before the Supreme Court, which replaced the Third Circuit's standard with a "tightly cabined" rule "especially appropriate" for the maritime context. And in one of the highest-profile Supreme Court cases in the 2018-2019 term, Jones Day defended the American Legion by convincing the Court to uphold the constitutionality of the Peace Cross in Bladensburg, Maryland, a government-maintained cross on public land that is a 93-year-old monument to the fallen of WWI.
This marks the third consecutive year that Jones Day has been named an Intellectual Property Practice Group of the Year. From today's leading technology companies, to cutting-edge pharmaceutical and life science innovators, to some of the most recognized brands in the world, Jones Day has protected and monetized some of the most valuable intellectual property rights. Once again, Jones Day was recognized for securing mission-critical results involving complex IP disputes in trial and appellate courts, as well administrative agencies throughout the United States and around the globe. With approximately 220 IP professionals, across 27 offices spanning four continents, our IP team collaboratively leverages advanced degrees and industry experience, courtroom prowess, and strategic business acumen to help clients achieve their goals.
In a global IP war against Apple Inc., Jones Day successfully represented Qualcomm Incorporated on multiple litigation fronts culminating in a favorable settlement in April 2019. Deploying the Firm's worldwide technology litigation capabilities, Jones Day represented Qualcomm in five patent lawsuits and in an antitrust, unfair competition and contract lawsuit in Southern District of California; in 45 IPR proceedings at the Patent Trial and Appeal Board; in a trade secret and contract lawsuit in California state court; and lawsuits in Taiwan and China.
This is the sixth time Jones Day has been named a Product Liability Practice Group of the Year. Jones Day product liability litigators have tried high-stakes, headline-making cases in state and federal courts throughout the United States. Most importantly, our work in the pharmaceutical area has led to numerous important and high profile representations. For example, Jones Day represented Merck in its unanimous win before the Supreme Court in a case involving Merck's prescription medicine Fosamax®. This was the first time the Court considered pre-emption in the context of name-brand drugs in nearly a decade, and it shifts the current plaintiff-friendly landscape back toward a more even playing field for manufacturers. It has been described as the most important pharmaceuticals case before the Court in the last 10 years. Jones Day leads the representation of Walmart Inc. in all facets of opioid litigation nationwide, including approximately 2,000 cases that make up the In re National Prescription Opiate Litigation Multi District Litigation, hundreds of state cases, and other related litigation.
As Jones Day's docket in this area of product liability is growing, we are also leading the way with thought leadership on emerging and complex legal issues. Another factor in being named to this list is the Firm's representation of R.J. Reynolds Tobacco Company in more than 3,400 Engle progeny lawsuits in Florida state courts resulting from the Florida Supreme Court's 2006 ruling in Engle v. Liggett Group, Inc., decertifying a class action of Florida smokers.
Law360 will profile the Jones Day Issues & Appeals, Intellectual Property, and Product Liability practices in the coming weeks.